Conceptio
›
Archive
›
IRIS
IRIS
metadata only
A Pilot Phase II Study of Erlotinib for the Treatment of Patients with Relapsed/Refractory Acute Myeloid Leukemia
Abou Dalle I et al.
IRIS · Papers
Open Source ↗
auto, research
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Cytomegalovirus reactivation can be a cause of DAT-negative hemolytic anemia in patients with chronic lymphocytic leukemia
#1039224
Hepatitis c virus infection risk tool for patients with cancer
#1039226
Second Cancers and Richter Transformation Are the Leading Causes of Death in Patients With Trisomy 12 Chronic Lymphocytic Leukemia
#1039228
Long-Term Outcomes for Patients With Chronic Lymphocytic Leukemia Who Discontinue Ibrutinib
#1039229
Immunohistochemical detection of ZAP70 in chronic lymphocytic leukemia predicts immunoglobulin heavy chain gene mutation status and time to progression
#1053709
Record
· ID 1039227
Retrieved via
Conceptio
— every document is proof-bundled with source, license, and retrieval metadata.